Data as of Sep 16
| -0.42 / -1.19%|
The 27 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 36.78, with a high estimate of 46.73 and a low estimate of 26.76. The median estimate represents a +5.25% increase from the last price of 34.95.
The current consensus among 30 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.